Spyre Therapeutics, Inc. (SYRE) has 10 identified peers for comparison in the Healthcare sector. Peers include ABCL, ARDX, CLDX, IMNM, MAZE, NTLA and others.
SYRE has a market capitalization of $4.17B, compared to an average peer market cap of $1.61B. SYRE is significantly larger than its average peer.
